医学
桥粒碱
支气管扩张
恶化
内科学
弹性蛋白
胃肠病学
哮喘
儿科
肺
病理
作者
Jeffrey T.-J. Huang,Elena Kuzmanova,Alison Dicker,Holly Rachael Keir,Simon Finch,Stefano Aliberti,Thomas C. Fardon,James Duncan Chalmers
出处
期刊:The European respiratory journal
[European Respiratory Society]
日期:2020-09-07
卷期号:: 4718-4718
被引量:2
标识
DOI:10.1183/13993003.congress-2020.4718
摘要
Introduction: Elastin degradation is a common pathological feature of bronchiectasis (BE) and cardiovascular (CV) disease. Our previous study has shown that elevated levels of serum desmosine (sDES), a degradation product from elastin, is strongly associated with an increased risk of severe exacerbation, but its long-term implication to CV outcomes is unknown. Aim: To investigate whether the levels of sDES are associated with long-term CV mortality in BE. Methods: Patients with BE (n=433, age 67 (58-74) years, FEV1(pred) 71.9 (50.0-91.0), female 60.7%, idiopathic bronchiectasis 45%, bronchiectasis severity Index (BSI) score 6 (4-10)) were included. sDES levels were measured using a stable isotope dilution LC-MS/MS method. Results: A total of 88 deaths (26 respiratory, 39 CV, 23 others) were recorded during the follow-up period of 6.7 years. Patients were divided into four quantiles based on serum desmosine levels. We found that elevated sDES levels were associated with all-cause mortality (HR 1.86 (1.46-2.37) per SD, p<0.0001, adjusted for BSI, Figure). There was also an association between sDES and respiratory death that occurred in the first 36 months (HR 1.62 (1.01-2.62) per SD, p=0.047, adjusted for BSI). In contrast, CV deaths occurred mostly after year 3 and were strongly associated with elevated sDES levels (HR 1.91 (1.35-2.71) per SD, p<0.0001, adjusted for BSI). Conclusion: sDES is an independent predictor of long-term CV risk in BE.
科研通智能强力驱动
Strongly Powered by AbleSci AI